Skip to content

A study to understand whether homoeopathic medicines given according to each person can help to treat psoriasis related to stress

A prospective interventional study on role of individualized homoeopathic medicine in the treatment of psoriasis with stress identified as causa occasionalis - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100368
Enrollment
45
Registered
2026-01-05
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine in appropriate potency according to the case will be prescribed after detail case taking and repertorization f

Sponsors

National Institute of Homoeopathy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed and stable patient suffering from Psoriasis Age group 18-60 years All sexes Patients exhibiting signs of mental stress confirmed by validated psychological scale such as Perceived Stress Scale PSS-10 Patients who can read understand English or Hindi or Bengali and if they are not able to read the physician can help in filling Providing written informed consent form

Exclusion criteria

Exclusion criteria: Cases suffering from uncontrolled systemic illness or life threatening infections Unwilling to take part and not giving consent to join the study Individuals diagnosed with eczema lichen planus or other skin conditions that may confound psoriasis assessment Patients suffering from major psychiatric illnesses such as schizophrenia bipolar disorder or substance use disorders that may affect stress assessment or compliance Pregnant women and lactating mothers Patients on systemic or topical corticosteroids or immunosuppressants as these can affect both skin symptoms and immune responses Substance abuse and or dependence

Design outcomes

Primary

MeasureTime frame
PASI SCORE The PASI Score Psoriasis Area and Severity Index is a widely used tool to measure the severity and extent of psoriasis It combines the severity of lesions and the area affected into a single score ranging from 0 no disease to 72 maximum severityTimepoint: PASI SCORE The PASI Score Psoriasis Area and Severity Index is a widely used tool to measure the severity and extent of psoriasis It combines the severity of lesions and the area affected into a single score ranging from 0 no disease to 72 maximum severity

Secondary

MeasureTime frame
DERMATOLOGICAL LIFE QUALITY INDEX DLQI The Dermatology Life Quality Index DLQI has 10 questions each is answered by a simple tick box method and scored 0 3 DLQI completion takes on average 2 minutes. By 2014 there were over 1000 articles describing the use of the DLQI in over 100 translations The aim of this questionnaire is to measure how much your skin problem has affected your life over the last week. Timepoint: Baseline and 6 months

Countries

India

Contacts

Public ContactDr Gobind Narayan Gupta

National Institute of Homoeopathy

dr.gn05gupta@gmail.com9163197805

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026